Analystreport

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations